Work / Illustration / MOA of Tigecycline
Tigecycline is an antibiotic that works by inhibiting protein synthesis. It is known to bind to the 30S ribosomal subunit in bacteria, restricting prokaryotic translation by preventing tRNA access.
Richard Satava, MD, Program Manager, Advanced Biomedical Technologies Program, DARPA
DARPA was very pleased with the Trauma Pod of the Future video. It was instrumental in presenting this futuristic and complex research program and provided an insight to the audience and reviewers that they would not have otherwise achieved. The quality of the work is exceptional and the video has been shown hundreds of times with great success; it is one of the most popular videos that I have used in my presentations.